Literature DB >> 15177885

Trefoil factor family (TFF) peptides and cancer progression.

Shahin Emami1, Sylvie Rodrigues, Christelle M Rodrigue, Nathalie Le Floch, Christine Rivat, Samir Attoub, Erik Bruyneel, Christian Gespach.   

Abstract

TFF peptides are involved in mucosal maintenance and repair through motogenic and antiapoptotic activities. These peptides are overexpressed during inflammatory processes and cancer progression. They also function as scatter factors, proinvasive and angiogenic agents. Such a divergence is related to the pathophysiological state of tissues submitted to persistent aggressive situations during digestive processes in the normal gastrointestinal tract, inflammatory and neoplastic diseases. In agreement with this model, TFF peptides are connected with multiple oncogenic pathways. As a consequence, the TFF signaling pathways may serve as potential targets in the control of chronic inflammation and progression of human solid tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177885     DOI: 10.1016/j.peptides.2003.10.019

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  35 in total

1.  Trefoil factor family peptide 2 acts pro-proliferative and pro-apoptotic in the murine retina.

Authors:  Adnana N Paunel-Görgülü; Andreas G Franke; Friedrich P Paulsen; Nicole Dünker
Journal:  Histochem Cell Biol       Date:  2011-04-22       Impact factor: 4.304

2.  Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma.

Authors:  Thaer Khoury; Krishdeep Chadha; Milind Javle; Kathleen Donohue; Charles Levea; Renuka Iyer; Haruhiko Okada; Hiroki Nagase; Dongfeng Tan
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Investigation of trefoil factor expression in saliva and oral mucosal tissues of patients with oral squamous cell carcinoma.

Authors:  Ponlatham Chaiyarit; Akasith Utrawichian; Chanvit Leelayuwat; Patrawut Vatanasapt; Nattharee Chanchareonsook; Mie Hessellund Samson; Andrew S Giraud
Journal:  Clin Oral Investig       Date:  2011-12-30       Impact factor: 3.573

4.  Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis.

Authors:  Jin Dai; Ning Zhang; Jinhui Wang; Minhu Chen; Jie Chen
Journal:  Tumour Biol       Date:  2014-01-10

5.  Effects of resistin-like molecule β over-expression on gastric cancer cells in vitro.

Authors:  Li-Duan Zheng; Chun-Lei Yang; Teng Qi; Meng Qi; Ling Tong; Qiang-Song Tong
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

6.  REDOX regulation of IL-13 signaling in intestinal epithelial cells: usage of alternate pathways mediates distinct gene expression patterns.

Authors:  Debasmita Mandal; Pingfu Fu; Alan D Levine
Journal:  Cell Signal       Date:  2010-06-04       Impact factor: 4.315

7.  TFF3 mediated induction of VEGF via hypoxia in human gastric cancer SGC-7901 cells.

Authors:  Bayasi Guleng; Jia Han; Jin-Qiu Yang; Qing-Wen Huang; Jian-Kun Huang; Xiao-Ning Yang; Jing-Jing Liu; Jian-Lin Ren
Journal:  Mol Biol Rep       Date:  2011-07-17       Impact factor: 2.316

8.  Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis.

Authors:  Thiruvengadam Arumugam; Will Brandt; Vijaya Ramachandran; Tood T Moore; Huamin Wang; Felicity E May; Bruce R Westley; Rosa F Hwang; Craig D Logsdon
Journal:  Pancreas       Date:  2011-08       Impact factor: 3.327

9.  TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.

Authors:  Ahmed El-Balat; Iryna Schmeil; Thomas Karn; Sven Becker; Nicole Sänger; Uwe Holtrich; Ruza Arsenic
Journal:  Pathol Oncol Res       Date:  2017-05-03       Impact factor: 3.201

10.  Validation of a rodent model of Barrett's esophagus using quantitative gene expression profiling.

Authors:  Daniel S Oh; Steven R DeMeester; Christy M Dunst; Ryutaro Mori; Bethany J Lehman; Hidekazu Kuramochi; Kathleen Danenberg; Peter Danenberg; Jeffrey A Hagen; Parakrama Chandrasoma; Tom R DeMeester
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.